C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 29,882 shares of the health services provider’s stock, valued at approximately $272,000.
Several other institutional investors and hedge funds have also modified their holdings of the business. Rhumbline Advisers boosted its stake in shares of Teladoc Health by 1.8% during the 4th quarter. Rhumbline Advisers now owns 281,420 shares of the health services provider’s stock worth $2,558,000 after acquiring an additional 5,018 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth $2,859,000. Summit Trail Advisors LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth $92,000. Murphy Pohlad Asset Management LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth $458,000. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of Teladoc Health by 21.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock worth $6,365,000 after acquiring an additional 125,111 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have recently weighed in on TDOC shares. Piper Sandler reiterated an “overweight” rating and set a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group lifted their target price on shares of Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Finally, Bank of America lifted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and a consensus target price of $12.18.
Insider Transactions at Teladoc Health
In other news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.95% of the company’s stock.
Teladoc Health Stock Performance
Teladoc Health stock opened at $12.75 on Friday. The company’s 50-day moving average price is $10.52 and its 200-day moving average price is $9.41. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $16.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a market cap of $2.19 billion, a PE ratio of -2.21 and a beta of 1.05.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
- Five stocks we like better than Teladoc Health
- How to Calculate Return on Investment (ROI)
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Differences Between Momentum Investing and Long Term Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is a Bond Market Holiday? How to Invest and Trade
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.